Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-11-15

• Fields of study

  Medicine

• Identifiers
  PMID 10582690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM classification

  2001cited by this paper
• Early detection of prostate cancer.

  1998cited by this paper
• Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells*

  1998cited by this paper
• Elevated expression of caveolin is associated with prostate and breast cancer.

  1998influential reference
• Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

  1998cited by this paper
• A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

  1998cited by this paper
• Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

  1998influential reference
• Upregulation of caveolin‐1 and caveolae organelles in Taxol‐resistant A549 cells

  1998cited by this paper
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  1997cited by this paper
• Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains.

  1997cited by this paper
• Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk

  1997cited by this paper
• Race and the histologic grade of prostate cancer

  1997cited by this paper
• Cancer statistics, 1996

  1996cited by this paper
• Long-term survival among men with conservatively treated localized prostate cancer.

  1995cited by this paper
• Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?

  1994cited by this paper
• Fresh tissue harvest for research from prostatectomy specimens

  1994cited by this paper
• Results of conservative management of clinically localized prostate cancer.

  1994cited by this paper
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

  1994cited by this paper
• Results of conservative management of clinically localized prostate cancer.

  1994cited by this paper
• Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

  1993cited by this paper
• The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

  1993cited by this paper
• The TNM classification of prostate cancer

  1992cited by this paper
• Early detection of prostate cancer.

  1992cited by this paper
• The risk of dying of prostate cancer in patients with clinically localized disease.

  1991cited by this paper
• The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.

  1991cited by this paper
• Prognostic significance of lymph nodal metastases in prostate cancer.

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.

  1972cited by this paper
• Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights

  2025cites this paper
• Cytotoxic properties of Thuya occidentalis hydroalcoholic extract on androgen unresponsive prostate cancer cells

  2024cites this paper
• Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer

  2023cites this paper
• Caveolin‐1 promotes mitochondrial health and limits mitochondrial ROS through ROCK/AMPK regulation of basal mitophagic flux

  2023cites this paper
• Identification and validation of a prognostic risk model based on caveolin family genes for breast cancer

  2022cites this paper
• Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients

  2021cites this paper
• Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis

  2021cites this paper
• Epigenetic field alterations in non-tumor prostate tissues detect prostate cancer in urine.

  2021cites this paper
• An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells

  2020cites this paper
• Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

  2020cites this paper
• Caveola-forming proteins and prostate cancer

  2020cites this paper
• Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer

  2020cites this paper
• Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS*

  2020cites this paper
• The Role of Src-Phosphorylation at the α1-Na/K-ATPase at Caveola in the Pathogenesis and Treatment of NASH Related Hepatocellular Carcinoma: Overview of Published Literature

  2020cites this paper
• An inverted Caveolin-1 topology defines a novel exosome secreted from prostate cancer cells

  2020cites this paper
• CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer

  2019cites this paper
• Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma

  2019cites this paper
• Caveolin-1 Expression Together with VEGF can be a Predictor for Lung Metastasis and Poor Prognosis in Osteosarcoma

  2019cites this paper
• The paracrine induction of prostate cancer progression by caveolin-1

  2019cites this paper
• Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis

  2019cites this paper
• Caveolins; An Assailant or An Ally of Various Cellular Disorders

  2019cites this paper
• Highlight article: The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer

  2019cites this paper
• [The role of caveolae in cataractogenesis: examination of human lens epithelial cells].

  2019cites this paper
• Knowledge, attitudes, and practices of health-care workers regarding hand hygiene guidelines in Al-Qassim, Saudi Arabia: A multicenter study

  2018cites this paper
• Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

  2018cites this paper
• Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.

  2018cites this paper
• Mesoscale organization of domains in the plasma membrane – beyond the lipid raft

  2018cites this paper
• Meta-analysis reveals no correlation of caveolin-1 G14713A (G>A) gene polymorphism with increased cancer risk in Taiwanese population

  2018cites this paper
• Loss of caveolin-1 in cancer associated fibroblasts promotes hepatocellular carcinoma development

  2018cites this paper
• ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer

  2018cites this paper
• Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.

  2017cites this paper
• The phospho–caveolin-1 scaffolding domain dampens force fluctuations in focal adhesions and promotes cancer cell migration

  2017cites this paper
• Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy

  2017cites this paper
• Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines

  2017cites this paper
• Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma

  2017cites this paper
• Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways.

  2017cites this paper
• Extracellular Vesicles: Prospects in Prostate Cancer Biomarker Discovery and Drug Delivery

  2017cites this paper
• Caveolin-1 is overexpressed in hypopharyngeal squamous cell carcinoma and correlates with clinical parameters

  2016cites this paper
• Oxidative stress in prostate hyperplasia and carcinogenesis

  2016cites this paper
• Analysis of caveolin‐1 and phosphoinositol‐3 kinase expression in primary uveal melanomas

  2016cites this paper
• Prognostic value of Caveolin‐1 in patients treated with radical prostatectomy: a multicentric validation study

  2016cites this paper
• Prognostic role of epithelial caveolin-1 in cancer : a meta-analysis

  2016cites this paper
• Anticancer potential of Azurin interaction with lipid rafts: deciphering the Role of Caveolae

  2016cites this paper
• Caveolin-1: a novel prognostic biomarker of radioresistance in cancer

  2016cites this paper
• Modulation of 17β‐Estradiol Signaling on Cellular Proliferation by Caveolin‐2

  2016cites this paper
• High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting

  2016cites this paper
• Caveolae and Caveolins: Multiple functions and Architectural Adaptation in various Head and Neck Diseases

  2016cites this paper
• Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer

  2016cites this paper
• Caveolin-1 and membrane domain regulation of focal adhesions and tumor cell migration

  2016influential citation
• Pattern of Prostate Specific Antigen and Gleason Score in Relation to Imunohistochemistry Features in Prostate Adenocarcinoma Patients in Dr. Hasan Sadikin General Hospital

  2016cites this paper
• Is Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?.

  2016cites this paper
• Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population

  2016cites this paper
• Caveolae and signalling in cancer

  2015cites this paper
• Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.

  2015cites this paper
• Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration

  2015cites this paper
• Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion

  2015cites this paper
• The effect of statins on cancer cells—review

  2015cites this paper
• Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis

  2015cites this paper
• Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial–mesenchymal transition

  2015cites this paper
• Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.

  2015influential citation
• Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel

  2015cites this paper
• γ‐oryzanol reduces caveolin‐1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines

  2015influential citation
• Caveolin-1 is a modulator of clonogenicity in renal cell carcinoma

  2015cites this paper
• Differentiation of high‐risk stage I and II colon tumors based on evaluation of CAV1 gene expression

  2015cites this paper
• The identification of prostate cancer associated tumour antigens and biomarkers

  2015cites this paper
• Neural map formation and sensory coding in the vomeronasal system

  2015cites this paper
• Cavin Family: New Players in the Biology of Caveolae.

  2015cites this paper
• Development of a Novel Method to Detect Prostate Cancer Circulating Tumor Cells (CTCs) Based on Epithelial-Mesenchymal Transition Biology

  2015cites this paper
• Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cells.

  2014cites this paper
• Expression profiles and functional associations of endogenous androgen receptor and caveolin‐1 in prostate cancer cell lines

  2014cites this paper
• The role of epithelial plasticity in prostate cancer dissemination and treatment resistance

  2014cites this paper
• Prostate cancer: the significance of the cAMP signalling pathway

  2014cites this paper
• Caveolin and cavin family members: dual roles in cancer.

  2014cites this paper
• Association of caveolin-1 genotypes with gastric cancer in Taiwan.

  2014cites this paper
• Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)

  2014cites this paper
• Functional polymorphisms of caveolin-1 variants as potential biomarkers of esophageal squamous cell carcinoma

  2014cites this paper
• Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.

  2014cites this paper
• TGF-β cascade regulation by PPP1 and its interactors –impact on prostate cancer development and therapy

  2014cites this paper
• Hypoxia-Inducible Factor/MAZ-Dependent Induction of Caveolin-1 Regulates Colon Permeability through Suppression of Occludin, Leading to Hypoxia-Induced Inflammation

  2014cites this paper
• Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion

  2014cites this paper
• Theroleofepithelialplasticityinprostatecancerdissemination and treatment resistance

  2014cites this paper
• Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer

  2014cites this paper
• Caveolin-1 interacts with protein phosphatase 5 and modulates its activity in prostate cancer cells.

  2013cites this paper
• The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.

  2013cites this paper
• Caveola-forming proteins caveolin-1 and PTRF in prostate cancer

  2013cites this paper
• Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines

  2013cites this paper
• Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer.

  2013influential citation
• Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis

  2013cites this paper
• Murine Models of Prostate Cancer

  2013cites this paper
• Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.

  2013cites this paper
• Caveolin-1 as a promoter of tumour spreading: when, how, where and why

  2013cites this paper
• PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer

  2013cites this paper
• Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men.

  2013cites this paper
• Significance of caveolin-1 regulators in pancreatic cancer.

  2013cites this paper
• Cancer Genes and Genomics Caveolin-1 Upregulation Contributes to c-Myc – Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

  2012cites this paper
• Changes in the location of oxytocin receptor in the human prostate

  2012cites this paper
• Effect of an angiotensin II type 1 receptor blocker on caveolin-1 expression in prostate cancer cells

  2012cites this paper
• The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review

  2012cites this paper
• From Department of Microbiology, Tumor and Cell Biology Karolinska Institutet, Stockholm, Sweden BASIS FOR RECLASSIFICATION OF NASOPHARYNGEAL CARCINOMA

  2012cites this paper
• Diet‐induced obesity increases melanoma progression: Involvement of Cav‐1 and FASN

  2012cites this paper